Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

Research out today is the latest to suggest that semaglutide can significantly lower people's risk of dementia.

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

The study, carried out by experts from the University of Nottingham and funded by the National Institute for Health Research ...

A blockbuster diabetes and weight-loss drug might be doing more than controlling blood sugar—it could also be protecting the brain. Researchers at Case Western Reserve University found that people ...

Although there’s no proper cure for dementia, prevention is possible even from a young age. It’s the spotting of early signs of the disease that helps in preventing the disease with an early ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

New research suggests that dementia prevention should begin much earlier than previously thought—possibly as early as ...

Over a hundred new drugs which could halt dementia are being developed at the “start of a journey to a cure”, scientists say. Experts have heralded the findings from a global review of drugs ...